---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-269347"
form_type: "8-K"
ticker: "INO"
cik: "0001055726"
company_name: "INOVIO PHARMACEUTICALS, INC."
filed_at: "2023-11-02T23:59:59+00:00"
generated_at: "2026-06-08T23:14:43.670386+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Inovio receives 180-day Nasdaq extension for minimum bid; stock transferred to Capital Market

## Summary
- Extension to April 29, 2024 to achieve $1.00 closing bid for 10 consecutive days.
- Common stock transferred from Nasdaq Global Market to Capital Market effective Nov 2, 2023.
- Failure to comply by April 29 may lead to delisting; company may appeal the determination.
- Company will consider reverse stock split among options to regain compliance.

## SEC filing metadata
- accession: 0001193125-23-269347
- form_type: 8-K
- ticker: INO
- cik: 0001055726
- company_name: INOVIO PHARMACEUTICALS, INC.
- filed_at: 2023-11-02T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1055726/000119312523269347/0001193125-23-269347-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1055726/000119312523269347/d580286d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-269347
- JSON: https://secwatch.observer/filing/0001193125-23-269347.json
- Plain text: https://secwatch.observer/filing/0001193125-23-269347.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.